75 related articles for article (PubMed ID: 19731237)
1. Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis.
Nahon P; Sutton A; Rufat P; Ziol M; Akouche H; Laguillier C; Charnaux N; Ganne-Carrié N; Grando-Lemaire V; N'Kontchou G; Trinchet JC; Gattegno L; Pessayre D; Beaugrand M
Hepatology; 2009 Nov; 50(5):1484-93. PubMed ID: 19731237
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants only improve hepatocellular carcinoma risk stratification in patients with alcohol-related cirrhosis?
Zeng L; Li X; Peng Z
J Hepatol; 2023 Dec; 79(6):e231-e232. PubMed ID: 36828034
[No Abstract] [Full Text] [Related]
3. Nuclear-localized, iron-bound superoxide dismutase-2 antagonizes epithelial lineage programs to promote stemness of breast cancer cells via a histone demethylase activity.
Coelho DR; Palma FR; Paviani V; He C; Danes JM; Huang Y; Calado JCP; Hart PC; Furdui CM; Poole LB; Schipma MJ; Bonini MG
Proc Natl Acad Sci U S A; 2022 Jul; 119(29):e2110348119. PubMed ID: 35858297
[TBL] [Abstract][Full Text] [Related]
4. Iron out, mitophagy in! A way to slow down hepatocellular carcinoma.
Aman Y; Cao S; Fang EF
EMBO Rep; 2020 Nov; 21(11):e51652. PubMed ID: 33155437
[TBL] [Abstract][Full Text] [Related]
5. Does SLC39A8 Ala391Thr confer risk of chronic liver disease?
Seidelin AS; Nordestgaard B; Tybjærg-Hansen A; Stender S
Antioxid Redox Signal; 2024 Apr; ():. PubMed ID: 38687342
[TBL] [Abstract][Full Text] [Related]
6. A variant in myeloperoxidase promoter hastens the emergence of hepatocellular carcinoma in patients with HCV-related cirrhosis.
Nahon P; Sutton A; Rufat P; Charnaux N; Mansouri A; Moreau R; Ganne-Carrié N; Grando-Lemaire V; N'Kontchou G; Trinchet JC; Pessayre D; Beaugrand M
J Hepatol; 2012 Feb; 56(2):426-32. PubMed ID: 21907168
[TBL] [Abstract][Full Text] [Related]
7. Gene polymorphisms in association with emerging cardiovascular risk markers in adult women.
Fan AZ; Yesupriya A; Chang MH; House M; Fang J; Ned R; Hayes D; Dowling NF; Mokdad AH
BMC Med Genet; 2010 Jan; 11():6. PubMed ID: 20078877
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in antioxidant defence genes and susceptibility to hepatocellular carcinoma in a Moroccan population.
Ezzikouri S; El Feydi AE; Afifi R; Benazzouz M; Hassar M; Pineau P; Benjelloun S
Free Radic Res; 2010 Feb; 44(2):208-16. PubMed ID: 19929244
[TBL] [Abstract][Full Text] [Related]
9. Functional variants in the catalase and myeloperoxidase genes, ambient air pollution, and respiratory-related school absences: an example of epistasis in gene-environment interactions.
Wenten M; Gauderman WJ; Berhane K; Lin PC; Peters J; Gilliland FD
Am J Epidemiol; 2009 Dec; 170(12):1494-501. PubMed ID: 19897513
[TBL] [Abstract][Full Text] [Related]
10. Influence of the polymorphism in candidate genes on late cardiac damage in patients treated due to acute leukemia in childhood.
Rajić V; Aplenc R; Debeljak M; Prestor VV; Karas-Kuzelicki N; Mlinaric-Rascan I; Jazbec J
Leuk Lymphoma; 2009 Oct; 50(10):1693-8. PubMed ID: 19863340
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of human acatalasemia. Identification of a splicing mutation.
Wen JK; Osumi T; Hashimoto T; Ogata M
J Mol Biol; 1990 Jan; 211(2):383-93. PubMed ID: 2308162
[TBL] [Abstract][Full Text] [Related]
12. Overview of hepatocellular carcinoma: from molecular aspects to future therapeutic options.
Panneerselvam S; Wilson C; Kumar P; Abirami D; Pamarthi J; Reddy MS; Varghese J
Cell Adh Migr; 2023 Dec; 17(1):1-21. PubMed ID: 37726886
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial heterogeneity in diseases.
Chen L; Zhou M; Li H; Liu D; Liao P; Zong Y; Zhang C; Zou W; Gao J
Signal Transduct Target Ther; 2023 Aug; 8(1):311. PubMed ID: 37607925
[TBL] [Abstract][Full Text] [Related]
14. Increased age, bilirubin, international normalized ratio, and creatinine score to triglyceride ratio are associated with alcohol-associated primary liver carcinoma: a single-centered retrospective study.
Jia X; Li R; Zhang X; Zhou T; Sun D; Yang N; Luo Z
Lipids Health Dis; 2023 Aug; 22(1):117. PubMed ID: 37537579
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology, clinical treatment patterns, and survival of hepatocellular carcinoma in Manitoba.
Hanumanthappa N; Cho BH; McKay A; Peretz D; Y Minuk G; Lambert P; Nashed M
Can Liver J; 2020; 3(2):194-202. PubMed ID: 35991857
[TBL] [Abstract][Full Text] [Related]
16. Synergistic and Detrimental Effects of Alcohol Intake on Progression of Liver Steatosis.
Di Ciaula A; Bonfrate L; Krawczyk M; Frühbeck G; Portincasa P
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269779
[TBL] [Abstract][Full Text] [Related]
17. Harnessing reactive oxygen/nitrogen species and inflammation: Nanodrugs for liver injury.
Liu M; Huang Q; Zhu Y; Chen L; Li Y; Gong Z; Ai K
Mater Today Bio; 2022 Jan; 13():100215. PubMed ID: 35198963
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress in obesity-associated hepatocellular carcinoma: sources, signaling and therapeutic challenges.
Brahma MK; Gilglioni EH; Zhou L; Trépo E; Chen P; Gurzov EN
Oncogene; 2021 Aug; 40(33):5155-5167. PubMed ID: 34290399
[TBL] [Abstract][Full Text] [Related]
19. The Roles of Neutrophils in the Pathogenesis of Liver Diseases.
Tang J; Yan Z; Feng Q; Yu L; Wang H
Front Immunol; 2021; 12():625472. PubMed ID: 33763069
[TBL] [Abstract][Full Text] [Related]
20. Alcohol and hepatocarcinogenesis.
Taniai M
Clin Mol Hepatol; 2020 Oct; 26(4):736-741. PubMed ID: 33053943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
